Neuralink has announced that it’s now accepting applications from subjects willing to have its experimental N1 computer interface implanted in their brain.
Elon Musk’s Neuralink company has announced that it’s now accepting applications from subjects willing to have its experimental N1 computer interface implanted in their brain.
Neuralink’s first in-human study, called PRIME (Precise Robotically Implanted Brain-Computer Interface), is encouraging interest from those with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS). They should also be at least 22 years old and have a consistent and reliable caregiver.
Musk said in 2022 that he intended to have the device implanted in his own brain, but it seems unlikely that he will be among the trial’s first batch of participants.
Formed in 2016, Neuralink is developing a technology that connects the human brain with a computer interface for a system that enables those with neurological conditions to communicate with and control various devices. A person with paralysis, for example, could potentially use their phone merely by imagining their hand movements.
